Cardiovascular
Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004–2015 cohort studies: no obesity paradox?
Nov
Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):59–60. https://doi.org/10.1056/NEJMOA020245.
Google Scholar
Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 2010;322(13):882–9. https://doi.org/10.1056/NEJM199003293221303.
Google Scholar
Yousufuddin M, Takahashi PY, Major B, et al. Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysis. BMJ Open. 2019;9(12):1–12. https://doi.org/10.1136/bmjopen-2018-028638.
Google Scholar
Janssen I, Mark AE. Elevated body mass index and mortality risk in the elderly. Obes Rev. 2007;8(1):41–59. https://doi.org/10.1111/J.1467-789X.2006.00248.X.
Google Scholar
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335(7630):1134–9. https://doi.org/10.1136/BMJ.39367.495995.AE.
Google Scholar
Banach M, Burchardt P, Chlebus K, et al. WYTYCZNE PTL/KLRwP/PTK/ PTDL/PTD/PTNT DIAGNOSTYKI I LECZENIA ZABURZEŃ LIPIDOWYCH W POLSCE 2021. Lekarz POZ Suplement. Published online 2021. https://www.termedia.pl/WYTYCZNE-PTL-KLRwP-PTK-r-nPTDL-PTD-PTNT-DIAGNOSTYKI-r-nI-LECZENIA-ZABURZEN-r-nLIPIDOWYCH-W-POLSCE-2021,166,45338,1,1.html
Global InfoBase W. The SuRF Report 2 Surveillance of chronic disease Risk Factors: Country-level data and comparable estimates The SuRF Report 2 CD-rom included The SuRF Report 2-Country-level data and comparable estimates.
Bentham J, Di Cesare M, Bilano V, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42. https://doi.org/10.1016/S0140-6736(17)32129-3.
Google Scholar
Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63(14):1345–54. https://doi.org/10.1016/J.JACC.2014.01.022.
Google Scholar
Alagiakrishnan K, Banach M, Ahmed A, Aronow WS. Complex relationship of obesity and obesity paradox in heart failure – higher risk of developing heart failure and better outcomes in established heart failure. Ann Med. 2016;48(8):603–13. https://doi.org/10.1080/07853890.2016.1197415.
Google Scholar
Dobrowolski P, Prejbisz A, Kuryłowicz A, et al. Guidelines/Recommendations Metabolic Syndrome Metabolic syndrome-a new definition and management guidelines. Agnieszka Mastalerz-Migas. 2022;16:24. https://doi.org/10.5114/aoms/152921.
Google Scholar
Osadnik K, Osadnik T, Gierlotka M, et al. Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004–2015 cohort studies. Eur J Prev Cardiol. 2023. https://doi.org/10.1093/eurjpc/zwad101.
Google Scholar
Kaess BM, Jóźwiak J, Nelson CP, et al. The relation of rapid changes in obesity measures to lipid profile—insights from a nationwide metabolic health survey in 444 Polish cities. PLoS ONE. 2014. https://doi.org/10.1371/JOURNAL.PONE.0086837.
Google Scholar
Jóźwiak J, Kasperczyk S, Tomasik T, et al. Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies. Arch Med Sci. 2020. https://doi.org/10.5114/aoms.2020.96052.
Google Scholar
Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5. https://doi.org/10.1161/CIRCULATIONAHA.109.192644.
Google Scholar
Rydén L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035–87. https://doi.org/10.1093/EURHEARTJ/EHT108.
Google Scholar
Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. Diabet Med. 1999;16(5):442–3. https://doi.org/10.1046/j.1464-5491.1999.00059.x.
Google Scholar
De G, Ambrosioni E, Borch-Johnsen K, et al. Executive summary European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis. 2004;173:381–91. https://doi.org/10.1016/S0021-9150(03)00419-2.
Google Scholar
Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72. https://doi.org/10.1001/JAMA.289.19.2560.
Google Scholar
Afzal S, Tybjærg-Hansen A, Jensen GB, Nordestgaard BG. Change in body mass index associated with lowest mortality in Denmark, 1976–2013. JAMA. 2016;315(18):1989–96. https://doi.org/10.1001/jama.2016.4666.
Google Scholar
Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368(9536):666–78. https://doi.org/10.1016/S0140-6736(06)69251-9.
Google Scholar
Niedziela J, Hudzik B, Niedziela N, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29(11):801–12. https://doi.org/10.1007/S10654-014-9961-9.
Google Scholar
Gravina G, Ferrari F, Nebbiai G. The obesity paradox and diabetes. Eat Weight Disord. 2021;26(4):1057–68. https://doi.org/10.1007/S40519-020-01015-1.
Google Scholar
Gurevitz C, Assali A, Mohsan J, et al. The obesity paradox in patients with acute coronary syndromes over 2 decades—the ACSIS registry 2000–2018. Int J Cardiol. 2023;380:48–55. https://doi.org/10.1016/j.ijcard.2023.03.038.
Google Scholar
Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine. Heart. 2009;95(6):454. https://doi.org/10.1136/hrt.2008.150524.
Google Scholar
Horwich TB, Fonarow GC, Clark AL. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis. 2018;61(2):151–6. https://doi.org/10.1016/J.PCAD.2018.05.005.
Google Scholar
Lee DH, Giovannucci EL. The obesity paradox in cancer: epidemiologic insights and perspectives. Curr Nutr Rep. 2019;8(3):175–81. https://doi.org/10.1007/S13668-019-00280-6.
Google Scholar
Shaw GB, Bosomworth NJ, Fcfp C. The downside of weight loss: realistic intervention in body-weight trajectory. Can Fam Physician. 2012;58(5):517.
Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96. https://doi.org/10.1016/S0140-6736(09)60318-4.
Google Scholar
Marcks N, Aimo A, Januzzi JL, et al. Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data. Clin Res Cardiol. 2021;110(8):1280–91. https://doi.org/10.1007/S00392-021-01822-1.
Google Scholar
Ali S, Garcia JM. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options—a mini-review. Gerontology. 2014;60(4):294–305. https://doi.org/10.1159/000356760.
Google Scholar
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726. https://doi.org/10.1093/EURHEARTJ/EHAB368.
Google Scholar
O’Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1439–50. https://doi.org/10.1001/JAMA.2009.454.
Google Scholar
Taylor RS, Walker S, Smart NA, et al. Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis. J Am Coll Cardiol. 2019;73(12):1430–43. https://doi.org/10.1016/J.JACC.2018.12.072.
Google Scholar
Prausmüller S, Heitzinger G, Pavo N, et al. Malnutrition outweighs the effect of the obesity paradox. J Cachexia Sarcopenia Muscle. 2022;13(3):1477–86. https://doi.org/10.1002/jcsm.12980.
Google Scholar
Harrington M, Gibson S, Cottrell RC. A review and meta-analysis of the effect of weight loss on all-cause mortality risk. Nutr Res Rev. 2009;22(1):93–108. https://doi.org/10.1017/S0954422409990035.
Google Scholar
Overvad TF, Rasmussen LH, Skjøth F, Overvad K, Lip GYH, Larsen TB. Body mass index and adverse events in patients with incident atrial fibrillation. Am J Med. 2013. https://doi.org/10.1016/J.AMJMED.2012.11.024.
Google Scholar
Springer J, Springer JI, Anker SD. Muscle wasting and sarcopenia in heart failure and beyond: update 2017. ESC Heart Fail. 2017;4(4):492–8. https://doi.org/10.1002/EHF2.12237.
Google Scholar
Emami A, Saitoh M, Valentova M, et al. Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). Eur J Heart Fail. 2018;20(11):1580–7. https://doi.org/10.1002/EJHF.1304.
Google Scholar
Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep. 2017;6(2):187. https://doi.org/10.1007/S13679-017-0262-Y.
Google Scholar
Wadden TA. The look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring). 2006;14(5):737. https://doi.org/10.1038/OBY.2006.84.
Google Scholar
Sørensen TIA, Rissanen A, Korkeila M, Kaprio J. Intention to lose weight, weight changes, and 18-y mortality in overweight individuals without co-morbidities. PLoS Med. 2005;2(6):0510–20. https://doi.org/10.1371/JOURNAL.PMED.0020171.
Google Scholar
Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553–64. https://doi.org/10.1111/DOM.14725.
Google Scholar
Huang S, Shi K, Ren Y, et al. Association of magnitude of weight loss and weight variability with mortality and major cardiovascular events among individuals with type 2 diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):78. https://doi.org/10.1186/s12933-022-01503-x.
Google Scholar
Orsi E, Solini A, Penno G, et al. Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes. Cardiovasc Diabetol. 2022;21(1):266. https://doi.org/10.1186/s12933-022-01706-2.
Google Scholar
Loeb LA, Ernster VL, Warner KE, Abbotts J, Laszlo J. Smoking and lung cancer: an overview. Cancer Res. 1984;44(12 Pt 1):5940–58.
Google Scholar
Cornfield J, Haenszel W, Hammond EC, Lilienfeld AM, Shimkin MB, Wynder EL. Smoking and lung cancer: recent evidence and a discussion of some questions. Int J Epidemiol. 2009;38(5):1175–91. https://doi.org/10.1093/IJE/DYP289.
Google Scholar
Dare S, Mackay DF, Pell JP. Relationship between smoking and obesity: a cross-sectional study of 499,504 middle-aged adults in the UK general population. PLoS ONE. 2015. https://doi.org/10.1371/JOURNAL.PONE.0123579.
Google Scholar
Watanabe T, Tsujino I, Konno S, et al. Association between smoking status and obesity in a nationwide survey of Japanese adults. PLoS ONE. 2016. https://doi.org/10.1371/JOURNAL.PONE.0148926.
Google Scholar
Borrelli B, Mermelstein R. The role of weight concern and self-efficacy in smoking cessation and weight gain among smokers in a clinic-based cessation program. Addict Behav. 1998;23(5):609–22. https://doi.org/10.1016/S0306-4603(98)00014-8.
Google Scholar
Veronese N, Li Y, Manson JE, Willett WC, Fontana L, Hu FB. Combined associations of body weight and lifestyle factors with all cause and cause specific mortality in men and women: prospective cohort study. BMJ. 2016. https://doi.org/10.1136/BMJ.I5855.
Google Scholar
Sperrin M, Candlish J, Badrick E, Renehan A, Buchan I. Collider bias is only a partial explanation for the obesity paradox. Epidemiology. 2016;27(4):525. https://doi.org/10.1097/EDE.0000000000000493.
Google Scholar
Banack HR, Stokes A. The ‘obesity paradox’ may not be a paradox at all. Int J Obes. 2017;41(8):1162–3. https://doi.org/10.1038/ijo.2017.99.
Google Scholar
Schneider EB. Collider bias in economic history research. Explor Econ Hist. 2020;78:101356. https://doi.org/10.1016/j.eeh.2020.101356.
Google Scholar
Ramsden CE, Zamora D, Majchrzak-Hong S, et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968–73). BMJ. 2016;353:i1246. https://doi.org/10.1136/bmj.i1246.
Google Scholar
Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–2559. https://doi.org/10.1056/NEJMoa0802743
Pavlov M, Nikolic-Heitzler V. Obesity paradox in acute myocardial infarction: is plasminogen activator inhibitor 1 the culprit? Med Hypotheses. 2023;176:111096. https://doi.org/10.1016/j.mehy.2023.111096.
Google Scholar
